Harbin Medical University
Clinical trials sponsored by Harbin Medical University, explained in plain language.
-
New triple-drug attack may crack tough breast cancer
Disease control OngoingThis study tests a new combination of drugs (camrelizumab, risedronate, and chemotherapy) in 30 women with triple-negative breast cancer. The goal is to see if adding risedronate can help overcome drug resistance and improve how well the cancer responds. The study is currently ac…
Phase: PHASE2 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Vitamin K2: a simple supplement to boost stroke recovery?
Symptom relief OngoingThis study tests whether taking vitamin K2 supplements for one year can improve muscle strength, muscle mass, and brain function in people who recently had an ischemic stroke. About 190 participants will receive either vitamin K2 or a placebo daily. Researchers will track their p…
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC